3 Millar A, McKew J, Taggart A. Fatal fibrosing alveolitis with certolizumab. Rheumatology
(Oxford) 2012; 51: 953–955. 4 Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, et al …

Introduction Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative
disorder worldwide. Although thoracic complications are frequent in CLL, only limited data …

Background Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative
disorder worldwide. Although thoracic complications are frequent in CLL, only limited data …

Rituximab is a mouse/human chimeric immunoglobulin G1 (IgG1)-к monoclonal antibody
that targets the CD20 antigen found on the surface of malignant and normal B lymphocytes …

Chronic lymphocytic leukaemia (CLL) is a common disorder. Patients typically present with
lymphadenopathy, splenomegaly and marked lymphocytosis (often> 100 000/μl). Although …

A 71-year-old man taking methotrexate for rheumatoid arthritis presented with a dry cough. A
chest X-ray and subsequent computed tomography (CT) of the chest revealed bilateral …

Patients with chronic lymphocytic leukemia (CLL) with relapsed disease and high-risk
disease features are at risk for transformation of their disease into a more aggressive form of …

Two cases of pulmonary chronic lympho-cytic leukemia (CLL) with high-resolution computed
tomography (HRCT) changes characterized by a bronchiolocentric distribution are reported …

Abstract Background. Lenalidomide (Len) is an immunomodulatory drug with single agent
activity in patients (pts) with treatment-naïve (TN) CLL,(overall response rate (ORR) 56-65 …

SIR, We read with interest the article by Glaspole et al.[1] in which the authors report a case
of certolizumabinduced interstitial lung disease (ILD) in a patient with RA. We would like to …